Clinical Trial Detail

NCT ID NCT02078609
Title A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

acute myeloid leukemia

bone marrow cancer

Therapies

LGH447

Age Groups: adult

No variant requirements are available.